vaccine patents where they got about $25 million in grants from the department’s Defense Advanced Research Projects Agency, or Darpa, for its vaccine technology, the newspaper said.“The company believes it has complied with applicable patent reporting requirements regarding patent filings, including as they relate to the Darpa program," Ray Jordan, a spokesman for Moderna, said Saturday.
The company estimates that Darpa funding was about $50 million, or 1% of its $5.1 billion total private funding.The newspaper cited Darpa spokesman Jared Adams as saying that all awards to Moderna included the need to report the role of government funding, adding that “Darpa is actively researching agency awards to Moderna to identify which patents and.